Evidence map›Paper›PMID 42030207›Full record

ReviewVirulence2026

The cell-type-specific roles of Toll-like receptors in herpes simplex virus infection and pathogenesis.

Haifeng Yu, Lina Wang, Jun Gong, Helin Lu, Wu Liu, Liqiong Ding

Abstract readReview
In one paragraph

Review in Virulence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Haifeng YuSchool of Pharmacy, Hubei University of Science and Technology, Xianning, China.
Lina WangOffice of Drug Clinical Trial Institution, Xianning Central Hospital, The First Affiliated Hospital of Hubei University of Science and Technology, Xianning, China.
Jun GongSchool of Pharmacy, Hubei University of Science and Technology, Xianning, China.
Helin LuSchool of Pharmacy, Hubei University of Science and Technology, Xianning, China.
Wu LiuSchool of Pharmacy, Hubei University of Science and Technology, Xianning, China.
Liqiong DingSchool of Pharmacy, Hubei University of Science and Technology, Xianning, China.ORCID 0000-0003-0508-7531

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Herpes simplex virus (HSV) initiates infection in mucosal epithelial cells, forming characteristic lesions before establishing lifelong latency in sensory neurons. The innate immune response to HSV is critically mediated by the Toll-like receptor (TLR) family. Expressed in a cell‑type‑specific manner, TLRs recognize viral components, leading to the production of interferons and pro-inflammatory cytokines. Different cell populations, by virtue of their unique TLR expression profiles and signaling contexts, mount specialized and non-redundant responses to the same viral pathogen. We systematically synthesize current research to elucidate the roles of specific TLRs in major cellular targets of HSV, including mucosal epithelial cells, fibroblasts, plasmacytoid dendritic cells, macrophages, peripheral neurons, and resident central nervous system cells. By examining how TLR-mediated sensing and signaling diverge across this cellular landscape, this article provides an integrated framework for understanding the coordinated, multi-layered immune defense against HSV and highlights the implications for pathogenesis and therapeutic strategies.

Indexed as

Herpes SimplexSimplexvirusToll-Like ReceptorsAnimalsCytokinesDendritic CellsEpithelial CellsHost-Pathogen InteractionsHumansImmunity, InnateInnate Immunity RecognitionInterferonsSignal TransductionCytokinesInterferonsToll-Like ReceptorsHSVinflammatory factorinterferonNF-κBToll-like receptors

Identifiers

PMID42030207
PMCPMC13114113

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.